Retatrutide: A New Horizon in Diabetes and Obesity Management
Retatrutide: A New Horizon in Diabetes and Obesity Management: evidence-based guidance reviewed against current NICE...
Retatrutide Phase 3 Results: What People With Type 2 Diabetes Should Know
Phase 3 retatrutide data in recent-onset type 2 diabetes showed A1C lowering and weight loss...
Omnipod Pod Correction: Under-Delivery Risk and What Users Should Check
Omnipod pod correction guide covering affected products, insulin under-delivery, high glucose, DKA risk, lot checks...
New Research Confirms GLP-1 Medications Protect the Heart, Not Just Blood Sugar
New Research Confirms GLP-1 Medications Protect the Heart, Not Just Blood Sugar: cardiovascular outcome trial...
Insulin cost caps help some commercially insured adults, but many insulin users remain unprotected
New Diabetes Care research explains why state insulin cost caps help some people, but leave...
Human vs Analogue Insulin in Young People With Type 1 Diabetes: What the HumAn-1 Trial Found
The HumAn-1 trial found no clear CGM advantage for glargine over usual-care human insulin regimens...
HIIT for Diabetes: Benefits, Limits, and Safety Checks
HIIT may help fitness and glucose for some people with diabetes, but it is not...
Heart Health and Type 2 Diabetes: What New Research Says About Modern Diabetes Medications
A new review of 133 randomized trials explains how modern type 2 diabetes medication classes...
Global Diabetes Trends: Key Statistics and Patient Takeaways
Key WHO diabetes statistics, what the historical data means, why dates matter, and why treatment...